Shariq Usmani, PhD
Boston, Massachusetts, United States of
America
Massachusetts General Hospital, Harvard
Medical School
Experience
Cabaletta Bio
Scientific Director / 2024
—
Present
I lead a research team in the
preclinical R&D
organization at Cabaletta bio.
I directly manage a talented
group of Senior Scientists,
Scientists and Research
Associates to spearhead and
drive innovation in cell
therapies and biologics in
autoimmune disease
indications.
Sana Biotechnology
Principal Scientist / 2022
—
2023
As a team lead, I led efforts
to establish in vivo genome
editing platform, vector
design/engineering and
optimization, with a broader
goal to develop innovative and
effective genomic medicine for
unmet medical needs.
Zohdan Bio
Consultant / 2024
—
Present
Providing strategic support
for all aspects of
preclinical, R&D programs
in gene therapy, genome
editing and virology and
immunology space.
Massachusetts General
Hospital
Senior Staff
Scientist / 2019
—
2022
Principal Investigator on an
NIH funded grant award to
study virus-immune interaction
and immune evasion mechanisms.
I directed all project aspects
including planning, writing,
finance/budgeting, and
supervision and mentoring of
direct reports. Developed a
novel multiphoton intravital
imaging platform to study
virus-immune cell interactions
in vivo in lymphoid and
mucosal tissues during acute
stages of HIV infection.
Research Expertise
Microbiology
Virology
Immunology
Molecular Biology
Genetics
And 5 more
About
Dr. Shariq Usmani is scientific
director at Cabaletta bio, a leader in
cell therapy for autoimmune diseases
(https://www.cabalettabio.com). He
leads a research team in preclinical
R&D organization at Cabaletta bio.
He directly manage a talented group of
Senior Scientists, Scientists and
Research Associates to spearhead and
drive innovation in cell therapies and
biologics in autoimmune disease
indications. <br> He is also
serves as consultant at Zohdan Bio,
where he provides strategic support
for preclinical R&D programs
focused on gene therapy, genome
editing, and virology. With a deep
foundation in oncology and biologics,
Dr. Usmani has led groundbreaking work
in both academia and industry,
including his tenures at Sana
Biotechnology, Harvard Medical School
and Massachusetts General Hospital.
He's led and spearheaded the
development of innovative in vivo
genome editing platforms, optimized
viral vectors, and engineered
cutting-edge reporter assays.